Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2024.

This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a

powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on November 4, 2024, might help the stock move higher if these key numbers are better than

expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business

conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus Estimate

This chemical company is expected to post quarterly earnings of $0.32 per share in its upcoming report, which represents a year-over-year change of -50%.

Revenues are expected to be $1.43 billion, down 4.2% from the year-ago quarter.

Estimate Revisions Trend

The consensus EPS estimate for the quarter has been revised 0.82% lower over the last 30 days to the current level. This is essentially a reflection of how the

covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.